Interviews with Key Opinion Leaders (KOLs) from Across the Stem Cell Industry

BioInformant's Founder, Cade Hildreth, has interviewed hundreds of key opinion leaders (KOL's) from across the stem cell industry.

Role of MSC-Derived Exosomes in Healing the Injured Spinal Cord – Interview with Dr. Askenase

August 24, 2016 By Cade Hildreth (CEO) Leave a Comment

MSC Exosomes, Dr. Askenase — Dr. Philip Askenase, Professor at Yale University School of Medicine

This is an interview with Philip Askenase, MD, Professor of Medicine and Pathology at Yale University School of Medicine. Dr. Askenase is an expert in the effector properties of exosomes who is now beginning to study mesenchymal stem cell (MSC)-derived exosomes and their role in regenerative processes.

Specifically, Dr. Askenase’s new unpublished preliminary work is focused on the role of MSC-derived exosomes in healing the injured spinal cord in rats.

In this interview, we discuss the growing importance of MSC-derived exosomes, including their advantages and applications. We also explore the market potential for stem cell exosomes, as well as companies competing in this emerging market area.

[Read more…]

Setting the Standard in Adipose-Derived Stem Cell Applications

August 15, 2016 By Cade Hildreth (CEO) Leave a Comment

This article is part two of my interview with Matthew Feshbach, CEO and Co-Founder of Okyanos (pronounced “Oh – key – AH – nos”). Founded in 2011, Okyanos specializes in treating patients with chronic, degenerative conditions. Located in Freeport, Grand Bahama, just 55 miles from the United States, Okyanos Cell Therapy combines a blend of stem and regenerative cells derived from a patient’s own adipose (fat) tissue.

Treatment is performed in their state-of-the-art surgical center by a team of U.S. licensed medical doctors. Okyanos is also fully licensed under the Bahamas Stem Cell Therapy and Research Act and adheres to U.S. surgical center standards.

Using technology from Cytori Therapeutics, the company offers a highly characterized cellular product that is administered via a robust protocol by a renowned medical team within a world-class facility. It is my opinion, that Okyanos is a company that is setting the standard for others practicing cellular therapy with adipose-derived stem and regenerative cells.

Enjoy this second half of the interview. If you haven’t read it yet, click here to view Part 1. [Read more…]

Use of Placental Tissue Matrix for Regenerative Medicine Applications

June 1, 2016 By Cade Hildreth (CEO) Leave a Comment

I am honored to release this interview with Bobby Ardila, V.P. of International Medical Communications for Neo Matrix, LLC. Neo Matrix is a newly formed cell therapy company serving the U.S.A. and South American markets. In this interview, we explore the company’s use of a placental tissue matrix component for regenerative medicine applications.

[Read more…]

Reversing Type I Diabetes with Encapsulated Cell Therapy Technology

May 31, 2016 By Cade Hildreth (CEO) 1 Comment

This is an interview with Gary Harlem, CEO of Altucell, a company exploring novel cell therapy approaches to treating Type I diabetes. In addition to diabetes, the company’s core encapsulation technology is applicable to a wide range of autoimmune and chronic degenerative disorders.

While Altucell is an American company, it has secured intellectual property rights on encapsulation patents from a team of researchers at the University of Perugia, Italy, led by Dr. Riccardo Calafiore, M.D. [Read more…]

Adult Stem Cell Therapies and the First Inter-American Stem Cell Conference

May 22, 2016 By Cade Hildreth (CEO) Leave a Comment

I am honored to release this interview with Ricardo de Cubas, Founder, President, and CEO of Regenestem, LLC. Regenestem is a medical practice company focused on adult stem cell therapies and physician training with particular growth in Latin America.

Regenestem is also presenting an upcoming conference in Cuba devoted to regenerative medicine, in association with the Cuban Institute of Hematology and Immunology. The First Inter American Stem Cell Conference will be held over October 13-15, at the Palacio de Convenciones, in Havana, to explore whether stem cell therapies are ready to become a standard form of treatment. It will also provide hands-on training workshops.

To learn more about progress with adult stem cell therapies and opportunities for education and collaboration in this area, enjoy the interview with Ricardo de Cubas below. [Read more…]

Enjoy this second half of the interview. If you haven’t read it yet, click here to view Part 1. [Read more…]

BioInformant's World-Class Clients